Sydney, Aug. 07, 2025 (GLOBE NEWSWIRE) — Pacific Green Technologies, Inc., a global leader in battery energy storage solutions, is pleased to announce that its Australian battery storage business has signed a [...] Read more »
Erste „Klimabürger“ von Nauru im weltweit ersten Programm zugelassen
AUCKLAND, Neuseeland, Aug. 05, 2025 (GLOBE NEWSWIRE) — Die Republik Nauru hat ihre ersten neuen Staatsbürger im Rahmen des Regierungsprogramms „Economic and Climate Resilience Citizenship Program” (Programm für [...] Read more »
Nauru accueille ses premiers citoyens du climat dans le cadre d’un programme inédit dans le monde
AUCKLAND, Nouvelle–Zélande, 05 août 2025 (GLOBE NEWSWIRE) — La république de Nauru a accueilli ses premiers nouveaux citoyens dans le cadre de l’Economic and Climate Resilience Citizenship Program [...] Read more »
Primeiros “cidadãos do clima” aprovados por Nauru em programa inédito no mundo
AUCKLAND, Nova Zelândia, Aug. 05, 2025 (GLOBE NEWSWIRE) — A República de Nauru deu as boas–vindas aos seus primeiros novos cidadãos no âmbito do Programa de Cidadania de Resiliência [...] Read more »
Pacific Green Signs Commitment Agreement With ZEN Energy for BESS Offtake in Australia for 1.5GWh
Sydney, Aug. 05, 2025 (GLOBE NEWSWIRE) — – Pacific Green is pleased to announce that its battery energy storage business in Australia has entered into a commitment agreement with ZEN Energy [...] Read more »
First ‘climate citizens’ approved by Nauru in world-first program
AUCKLAND, New Zealand, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Republic of Nauru has welcomed its first new citizens under the government’s Economic and Climate Resilience Citizenship Program, announced at COP29 late last [...] Read more »
Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025:
Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines [...] Read more »
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:
Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the [...] Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »
Informations sur le nombre total de droits de vote et d'actions
INFORMATION RÉGLEMENTÉE
Informations sur le nombre total de droits de vote et d'actions
Mont–Saint–Guibert [...] Read more »
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
Mont–Saint–Guibert, Belgium – [...] Read more »
Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025
Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025
Mont–Saint–Guibert, Belgique – Mardi 29 [...] Read more »
Meltwater Debuts Industry-First GenAI Lens, Unlocking Enhanced Brand Insights
SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Read more »
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine
Mont–Saint–Guibert, Belgique – 28 [...] Read more »
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Mont–Saint–Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm [...] Read more »